Lotus Pharmaceuticals Statistics
Total Valuation
LTUS has a market cap or net worth of 15.34 million.
| Market Cap | 15.34M |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
LTUS has 2.64 billion shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 2.64B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 0.09.
| PE Ratio | 0.09 |
| Forward PE | n/a |
| PS Ratio | 0.21 |
| PB Ratio | 0.15 |
| P/TBV Ratio | 0.19 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 0.83 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.53, with a Debt / Equity ratio of 0.06.
| Current Ratio | 0.53 |
| Quick Ratio | 0.43 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.60 |
| Debt / FCF | -7.70 |
| Interest Coverage | 32.90 |
Financial Efficiency
Return on equity (ROE) is 1.82% and return on invested capital (ROIC) is 5.04%.
| Return on Equity (ROE) | 1.82% |
| Return on Assets (ROA) | 4.56% |
| Return on Invested Capital (ROIC) | 5.04% |
| Return on Capital Employed (ROCE) | 7.71% |
| Revenue Per Employee | 186,399 |
| Profits Per Employee | 4,489 |
| Employee Count | n/a |
| Asset Turnover | 0.64 |
| Inventory Turnover | 37.27 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +20.00% in the last 52 weeks. The beta is -2.64, so LTUS's price volatility has been lower than the market average.
| Beta (5Y) | -2.64 |
| 52-Week Price Change | +20.00% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 51.45 |
| Average Volume (20 Days) | 36,247 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, LTUS had revenue of 71.39 million and earned 1.72 million in profits. Earnings per share was 0.06.
| Revenue | 71.39M |
| Gross Profit | 25.45M |
| Operating Income | 8.17M |
| Pretax Income | 1.49M |
| Net Income | 1.72M |
| EBITDA | 10.31M |
| EBIT | 8.17M |
| Earnings Per Share (EPS) | 0.06 |
Balance Sheet
The company has 158,908 in cash and 6.18 million in debt, giving a net cash position of -6.02 million or -0.00 per share.
| Cash & Cash Equivalents | 158,908 |
| Total Debt | 6.18M |
| Net Cash | -6.02M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | 99.45M |
| Book Value Per Share | 3.58 |
| Working Capital | -6.64M |
Cash Flow
In the last 12 months, operating cash flow was 18.37 million and capital expenditures -19.17 million, giving a free cash flow of -802,955.
| Operating Cash Flow | 18.37M |
| Capital Expenditures | -19.17M |
| Free Cash Flow | -802,955 |
| FCF Per Share | -0.00 |
Margins
Gross margin is 35.65%, with operating and profit margins of 11.44% and 2.43%.
| Gross Margin | 35.65% |
| Operating Margin | 11.44% |
| Pretax Margin | 2.08% |
| Profit Margin | 2.43% |
| EBITDA Margin | 14.43% |
| EBIT Margin | 11.44% |
| FCF Margin | n/a |
Dividends & Yields
LTUS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.11% |
| Shareholder Yield | -4.11% |
| Earnings Yield | 11.21% |
| FCF Yield | -5.24% |
Stock Splits
The last stock split was on December 31, 2010. It was a reverse split with a ratio of 0.5.
| Last Split Date | Dec 31, 2010 |
| Split Type | Reverse |
| Split Ratio | 0.5 |
Scores
LTUS has an Altman Z-Score of 2.58. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.58 |
| Piotroski F-Score | n/a |